MXN
15.69
May 9
Business Description
CSPC Pharmaceutical Group Ltd
ISIN : HK1093012172
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 18.52 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.1 | |||||
Interest Coverage | 271.7 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 6.33 | |||||
Beneish M-Score | -1.92 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.4 | |||||
3-Year EBITDA Growth Rate | 3.2 | |||||
3-Year EPS without NRI Growth Rate | 3.6 | |||||
3-Year FCF Growth Rate | -25.6 | |||||
3-Year Book Growth Rate | 11.3 | |||||
Future 3-5Y EPS without NRI Growth Rate | 10.05 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.26 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -27.02 | |||||
12-1 Month Momentum % | -27.02 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.63 | |||||
Quick Ratio | 2.32 | |||||
Cash Ratio | 1.29 | |||||
Days Inventory | 110.77 | |||||
Days Sales Outstanding | 58.87 | |||||
Days Payable | 94.58 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 12.8 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 3.84 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 70.49 | |||||
Operating Margin % | 22.3 | |||||
Net Margin % | 18.66 | |||||
FCF Margin % | 7.1 | |||||
ROE % | 18.47 | |||||
ROA % | 13.36 | |||||
ROIC % | 25.69 | |||||
ROC (Joel Greenblatt) % | 65.35 | |||||
ROCE % | 21.44 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 12.57 | |||||
Forward PE Ratio | 11.99 | |||||
PE Ratio without NRI | 12.57 | |||||
Shiller PE Ratio | 11.55 | |||||
Price-to-Owner-Earnings | 25.24 | |||||
PEG Ratio | 0.89 | |||||
PS Ratio | 2.35 | |||||
PB Ratio | 2.24 | |||||
Price-to-Tangible-Book | 2.42 | |||||
Price-to-Free-Cash-Flow | 32.42 | |||||
Price-to-Operating-Cash-Flow | 17.77 | |||||
EV-to-EBIT | 8.2 | |||||
EV-to-Forward-EBIT | 6.52 | |||||
EV-to-EBITDA | 8.2 | |||||
EV-to-Forward-EBITDA | 6.18 | |||||
EV-to-Revenue | 1.93 | |||||
EV-to-Forward-Revenue | 1.51 | |||||
EV-to-FCF | 26.72 | |||||
Price-to-Projected-FCF | 1.03 | |||||
Price-to-DCF (Earnings Based) | 0.41 | |||||
Price-to-DCF (FCF Based) | 1.08 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.9 | |||||
Price-to-Graham-Number | 1.16 | |||||
Price-to-Net-Current-Asset-Value | 5.43 | |||||
Earnings Yield (Greenblatt) % | 12.2 | |||||
FCF Yield % | 3.07 | |||||
Forward Rate of Return (Yacktman) % | 18.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
CSPC Pharmaceutical Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 77,540.898 | ||
EPS (TTM) (MXN) | 1.217 | ||
Beta | 0 | ||
Volatility % | 27.32 | ||
14-Day RSI | 0 | ||
14-Day ATR (MXN) | 0.000037 | ||
20-Day SMA (MXN) | 15.69 | ||
12-1 Month Momentum % | -27.02 | ||
52-Week Range (MXN) | 15.69 - 21.5 | ||
Shares Outstanding (Mil) | 11,896.09 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
CSPC Pharmaceutical Group Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
CSPC Pharmaceutical Group Ltd Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
CSPC Pharmaceutical Group Ltd Frequently Asked Questions
What is CSPC Pharmaceutical Group Ltd(MEX:1093)'s stock price today?
When is next earnings date of CSPC Pharmaceutical Group Ltd(MEX:1093)?
Does CSPC Pharmaceutical Group Ltd(MEX:1093) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |